Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer

Journal of the National Cancer Institute

Volumn 87, Issue 6, 1995, Pages 446-451

  Roodi, Nady ^a   Bailey, L Renee ^a   Kao, Woei Yau ^a   Verrier, Carmel S ^a   Yee, Cindy J ^a   Dupont, William D ^a   Parl, Fritz F ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CLINICAL FEATURE; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM;

BASE SEQUENCE; BREAST NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; POINT MUTATION; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION, GENETIC;

EID: 0028934347     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.6.446     Document Type: Article

References (48)

1. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240:889-895. 1988.
2. Beato M: Gene regulation by steroid hormones. Cell 56:335-344, 1989.
3. Wahli W, Martinez E: Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J 5:2243-2249,1991.
4. Gosden JR, Middleton PG, Rout D: Localization of the human oestrogen receptor gene to chromosome 6q24-q27 by in situ hybridization. Cytogenet Cell Genet 43:218-220, 1986.
5. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 7:3385-3388, 1988.
6. Keaveney M, Klug J, Dawson MT, et al: Evidence for a previously unidentified upstream exon in the human oestrogen receptor gene. J Mol Endocrinol 6:111-115, 1991.
7. McGuire WL, Clark GM: Role of progesterone receptors in breast cancer. Semin Oncol 12(Suppl 1): 12-16, 1985.
8. Jensen EV: Steroid receptors in breast cancer: historical perspective. Cancer 46(12 Suppl): 2759-2761, 1980.
9. McGuire WL, Carbone PP, Vollmer RP, eds: Estrogen Receptors in Human Breast Cancer. New York: Raven Press, 1975.
10. Lippman ME, Allegra JC: Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer 46:2829-2834, 1980.
11. Osborne CK, Yochmowitz MG, Knight WA, et al: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884-2888,1980.
12. Maass H, Jonat W, Stolzenbach G, et al: The problem of non-responding estrogen receptorpositive patients with advanced breast cancer. Cancer 46(12 Suppl):2835-2837, 1980.
13. Manni A, Arafah B, Pearson OH: Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Cancer 46(12 Suppl):2838-2841, 1980.
14. Jensen EV: Hormone dependency of breast cancer. Cancer 47:2319-2326, 1981.
15. Hill SM, Fuqua SA, Chamness GC, et al: Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 49:145-148,1989.
16. Pari FF, Cavener DR, Dupont WD: Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 14: 5764, 1989.
17. Yaich L, Dupont WD, Cavener DR, et al: Analysis of the PvmII restriction fragment-length polymorphism and exon structure of the estrogen receptor- gene- in breast cancer and peripheral blood. Cancer Res 52:77-83,1992.
18. Beahrs OH, Henson DE, Hutter RVP. et al. eds: Staging for carcinoma of the breast. In Manual for Staging of Cancer, 3rd ed. Philadelphia: Lippincott, 1988, pp 145-150.
19. Pari FF, Posey YF: Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer. Human Pathol 19:960-966, 1988.
20. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
21. Green S, Walter P, Kumar V, et al: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature320:134-139,1986.
22. Kumar V, Green S, Staub A, et al: Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5:2231-2236, 1986.
23. Borresen AL, Hovig E, Smith-Sprensen B, et al: Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci U S A 88:8405-8409, 1991.
24. Myers RM, Maniatis T, Lerman LS: Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527, 1987.
25. Orita M, Sekiya T, Hayashi K: DNA sequence polymorphisms in Alu repeats. Genomics8:271-278, 1990.
26. Breslow NE, Day NE: Statistical Methods in Cancer Research, Vol 1-The Analysis of Case-Control Studies. Lyon: IARC, 1980, pp 191-279.
27. Fleiss JL: Statistical Methods for Rates and Proportions, 2d ed. New York: John Wiley and Sons, 1981.
28. Elston RC, Forthofer R: Testing for the Hardy-Weinberg equilibrium in small samples. Biometrics 33:536-542, 1977.
29. Kendall MG, Stuart A: The Advanced Theory of Statistics, vol 2, Inference and Relationship, 3d ed. New York: Hafner, 1973, pp 234-272.
30. Sluyser M: Steroid/thyroid receptor-like proteins with oncogenic potential: a review. Cancer Res 50:451-458, 1990.
31. Graham ML2rd, Krett NL, Miller LA, et al: T47Dco cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. Cancer Res 50:6208-6217, 1990.
32. Caleffi M, Teague MW, Jensen RA, et al: p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 73:2147-2156,1994.
33. Cooper DN, Krawczak M: The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 85:55-74, 1990.
34. Krawczak M, Cooper DN: Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA environment. Hum Genet 86:425-441, 1991.
35. Tomaletti S, Pfeifer GP: Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer [see comment citation in Medline]. Science 263:1436-1438, 1994.
36. Gao S, Drouin R, Holmquist GP: DNA repair rates mapped along the human PGK1 gene at nucleotide resolution [see comment citation in Medline]. Science 263:1438-1440, 1994.
37. Tora L, White J, Brou C, et al: The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell59:477-487, 1989.
38. Lees JA, Fawell SE, Parker MG: Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res17:5477-5488,1989.
39. Krust A, Green S, Argos P, et al: The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 5:891-897, 1986.
40. Pakdel F, Le Guellec C, Vaillant C, et al: Identification and estrogen induction of two estrogen receptors (ER) messenger ribonucleic acids in the rainbow trout liver sequence homology with other ERs. Mol Endocrinol 3:44-51, 1989.
41. McGuire WL, Chamness GC, Fuqua SA: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5:1571-1577, 1991.
42. Kamik PS, Kulkami S, Liu XP, et al: Estrogen receptor mutations m tamoxifen-resistant breast cancer. Cancer Res 54:349-353, 1994.
43. Trapman J, Brinkmann AO: Mutations in the androgen receptor. Ann N Y Acad Sci 684:8593,1993.
44. Newmark JR, Hardy DO, Tonb DC, et al: Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA: 89:6319-6323,1992.
45. Dotzlaw H, Alkhalaf M, Murphy LC: Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol6:773-785,1992.
46. Fuqua SA, Fitzgerald SD, Allred DG, et al: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52:483-486, 1992.
47. Ottaviano YL, Issa JP, Pari FF, et al: Methyla-tion of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res54:2552-2555,1994.
48. Zuppan P, Hall JM, Lee MK, et al: Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48:1065-1068,1991.